Streamline Health Solutions, Inc. Stock

Equities

STRM

US86323X1063

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-06-14 pm EDT 5-day change 1st Jan Change
0.5099 USD -1.96% Intraday chart for Streamline Health Solutions, Inc. +10.85% +19.98%
Sales 2025 * 20.01M Sales 2026 * 20.82M Capitalization 30.26M
Net income 2025 * -7M Net income 2026 * -6M EV / Sales 2025 * 1.51 x
Net cash position 2025 * - Net cash position 2026 * - EV / Sales 2026 * 1.45 x
P/E ratio 2025 *
-3.92 x
P/E ratio 2026 *
-4.64 x
Employees 77
Yield 2025 *
-
Yield 2026 *
-
Free-Float 77.36%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Streamline Health Solutions, Inc.

1 day-1.96%
1 week+10.85%
Current month+30.74%
1 month+59.34%
3 months+4.27%
6 months+35.97%
Current year+19.98%
More quotes
1 week
0.40
Extreme 0.3951
0.65
1 month
0.31
Extreme 0.31
0.65
Current year
0.24
Extreme 0.24
0.65
1 year
0.21
Extreme 0.213
1.48
3 years
0.21
Extreme 0.213
2.35
5 years
0.21
Extreme 0.213
3.86
10 years
0.21
Extreme 0.213
5.77
More quotes
Managers TitleAgeSince
Chief Executive Officer 35 12-12-31
Director of Finance/CFO 48 20-06-30
Chairman 52 18-08-06
Members of the board TitleAgeSince
Director/Board Member 50 19-12-09
Director/Board Member 51 Feb. 06
Director/Board Member 51 05-04-30
More insiders
Date Price Change Volume
24-06-14 0.5099 -1.96% 35,541
24-06-13 0.5201 +0.99% 70,108
24-06-12 0.515 -19.53% 330,179
24-06-11 0.64 +38.98% 926,005
24-06-10 0.4605 +0.11% 74,518

Delayed Quote Nasdaq, June 14, 2024 at 04:00 pm EDT

More quotes
Streamline Health Solutions, Inc. enables healthcare organizations to proactively address revenue leakage and improve financial performance. The Company delivers integrated solutions, technology-enabled services and analytics. It operates in one segment as a provider of health information technology solutions and associated services that improve healthcare processes and information flows within a healthcare facility. The Company sells its solutions and services in North America to hospitals and health systems through its direct sales force and its reseller partnerships. It offers solutions and services to assist its clients in revenue cycle management, including its two flagship technologies: RevIDTM and eValuatorTM. RevID offers automated, daily reconciliation of clinical event activity to patient billing charge items prior to billing. eValuator provides 100% automated coding analysis prior to billing. It offers an array of professional services, including system implementation.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5099 USD
Average target price
1.5 USD
Spread / Average Target
+194.18%
Consensus